Literature DB >> 6886133

Computed tomography in Crohn disease.

D H Frager, M Goldman, T C Beneventano.   

Abstract

Twelve patients with Crohn disease were studied by computed tomography. Characteristic findings of small intestinal involvement include symmetrical bowel wall thickening, a "double halo" appearance on cross section of the diseased bowel segment, and an associated mesenteric fat mass. Computed tomography provided crucial diagnostic information in the management of some of the intestinal and extraintestinal complications of the disease.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6886133     DOI： 10.1097/00004728-198310000-00012

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN： 0363-8715            Impact factor:   1.826


  6 in total

1.  Spiral CT demonstration of hypervascularity in Crohn disease: "vascular jejunization of the ileum" or the "comb sign".

Authors:  M A Meyers; P V McGuire
Journal:  Abdom Imaging       Date:  1995 Jul-Aug

2.  [Acute intestinal inflammation].

Authors:  M Hittinger; M F Reiser; C J Zech
Journal:  Radiologe       Date:  2010-03       Impact factor: 0.635

3.  CT of complicated inflammatory bowel disease in children.

Authors:  M M Riddlesberger
Journal:  Pediatr Radiol       Date:  1985

4.  Multidetector computed tomography in large bowel lesions-a study of 100 cases.

Authors:  Chhaya Jagat Bhatt; Love N Patel; Mihir Baraiya; Kalpesh K Patel; Kavita U Vaishnav; Dharita S Shah
Journal:  Indian J Surg       Date:  2011-08-05       Impact factor: 0.656

5.  Ultrasonographic evaluation of the bowel wall in inflammatory bowel disease: comparison of in vivo and in vitro studies.

Authors:  J Hata; K Haruma; H Yamanaka; J Fujimura; M Yoshihara; T Shimamoto; K Sumii; G Kajiyama; T Yokoyama
Journal:  Abdom Imaging       Date:  1994 Sep-Oct

6.  Value of computed tomography in the detection of complications of Crohn's disease.

Authors:  R M Gore; M I Cohen; R L Vogelzang; H L Neiman; T K Tsang
Journal:  Dig Dis Sci       Date:  1985-08       Impact factor: 3.199
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.